PRELIMINARY SCIENTIFIC PROGRAM As of December 28, :30-16:00 PARALLEL INDUSTRY WORKSHOP PARALLEL INDUSTRY WORKSHOP PARALLEL INDUSTRY WORKSHOP
|
|
- Lindsey Fowler
- 6 years ago
- Views:
Transcription
1 PRELIMINARY SCIENTIFIC PROGRAM As of December 28, 2017 Wednesday, 14 February :30-16:00 INDUSTRY WORKSHOP INDUSTRY WORKSHOP INDUSTRY WORKSHOP 16:15-17:45 INDUSTRY WORKSHOP INDUSTRY WORKSHOP INDUSTRY WORKSHOP 18:00-19:00 OPENING CEREMONY Moshe Phillip - Opening Remarks Thomas Danne Beyond A1c: Consensus on CGM Outcomes 19:00-20:00 Networking Reception in the Exhibition Area
2 Thursday, 15 February :00-09:30 PLENARY SESSION (1) COPING WITH GLUCOSE VARIABILITY Stephanie Amiel Reversibility of Brain Changes in Satish Garg - Role of Concentrated Insulins in Care Bruce Bode - Review of Ultra-Rapid Acting Insulins Jennifer Sherr - Nasal Glucagon: an alternative innovative needle free approach for the treatment of severe hypoglycemia 09:30-10:00 10:00-10:30 10:30-12:00 12:00-13:00 13:00-14:30 Lunch Break SESSION (2) GLUCOSE METRICX: BEYOND HbA1c SESSION (3) S OF START-UP COMPANIES SESSION (4) NEXT GENERATION SOLUTIONS INDUSTRY WORKSHOP INDUSTRY WORKSHOP Irl Hirsch - Time in Ranges or HbA1c? Richard Bergenstal - Glucose Variability: Which Measures Are Clinically Meaningful? Hans DeVries - Glycation Gap: Does It Exist? Simon Heller - Hypoglycemia and Mortality: A Causal Relationship? Join this session to meet the start-up finalists and unpack their ideas. Judged by ATTD s expert panel as the most exciting innovations from the largest number of entries we have ever had, this session is a must for the investor community and those with an eye out for the next big thing. David Klonoff - Trends in Digital Health for Francis Doyle III - Dealing with Patient and Device Uncertainty in the Artificial Pancreas: Multi-zones, Adaptation, and Trust Indices Eyal Dassau Next Generation Automated Insulin Delivery: On- Body Ecosystem for Automated Insulin Delivery in Type 1 Neal Kaufman - Digital Self- Management Support
3 14:30-15:00 15:00-16:30 16:40-18:00 SESSION (5) DEBATE: PUMP V. SENSOR WHAT IS MORE IMPORTANT? SESSION (6) IT IS NOT JUST ABOUT GLUCOSE Interventions: Foundational to Improving Health Outcomes SESSION (7) ACCESS TO NOVEL TECHNOLOGY SESSION 1 SESSION 2 Lalantha Leelarathna Pumps Hans DeVries Sensors Discussion Lori Laffel Aligning Patient Expectations with Automated Insulin Delivery System: Understanding Patients Reported Outcomes Katharine Barnard Supporting Healthcare Professionals: Finding the QoL Balance Pratik Choudhary Understanding the Relationship Between Distress and Metabolic Outcomes Irl Hirsch - Cost of Medications Vs. Outcomes: Is there an End George Grunberger We Have the Technology, We Have the Data, and Now What? Aaron Kowalski - The Role of Patients in Increasing Access to New Treatments Henk J. Veeze - Value Based Health Care / Diabeter Experience
4 Friday, 16 February :00-08:50 09:00-10:00 MORNING SYMPOSIUM SESSION (8) CLOSING THE LOOP - NIH- FUNDED AP RESEARCH EFFORTS Boris Kovatchev - The International Closed-Loop (idcl) Trial Roman Hovorka - Day and Night Closed-loop in Young People with Type 1 (DAN05) Richard Bergenstal - A Crossover Study Comparing Two Automated Insulin Delivery System Algorithms in Adolescents and Young Adults with Type 1 Steven Russell - Bionic Pancreas Treats Adults with Type 1 SESSION (9) BIOTECHNOLOGY AND DIABETES Desmond Schatz Update on Worldwide Efforts to Prevent Type 1 Mark Sperling: Posttransplant in Children and Adolescents Lorenzo Piemonti - Beta Cell Replacement, Where Are We? SESSION (10) 09:00-09:30 Stayce Beck Moving Forward With Regulatory Approval INDUSTRY WORKSHOP 09:40-10:00 INDUSTRY WORKSHOP SESSION 3 SESSION (11) S OF START-UP COMPANIES 10:00-10:30 10:30-12:00 12:00-13:00 13:00-14:30 Lunch Break PLENARY SESSION (12) ATTD YEARBOOK Satish Garg/Irl B. Hirsch -Self-monitoring of Blood Glucose Bruce Bode/Tadej Battelino - Continuous Glucose Monitoring John Pickup - Insulin Pumps
5 Eyal Dassau/Revital Nimri - Closing the Loop Jan Bolinder/Thomas Danne/Lutz Heinemann - New Insulins, biosimilars, and Insulin Therapy Neal Kaufman - Using Digital Health Technology to Prevent and Treat, Helen Murphy - Technology and Pregnancy Desmond Schatz/Natasa Bratina - Immune Intervention for type 1 diabetes, Michael C. Riddell - Advances in Exercise Physical Activity and Mellitus, Shlomit Shalitin/David Maahs - Technology and Therapy in the Pediatric Age Group Alon Liberman/Katharine Barnard - Technology and the Human Factor Satish Garg - New Medications for the Treatment of 14:30-15:00 15:00-16:30 16:40-18:00 SESSION (13) NUTRITION AND FOOD TECHNOLOGIES SESSION (14) MAJOR OUTCOME STUDIES: THE HypoDE STUDY SESSION (15) CLINICAL DECISION SUPPORT SYSMTESM (ADVISORS) SESSION (16) ISPAD SESSION CHALLENGES WITH DIABETES TECHNOLOGY IN PEDIATRICS INDUSTRY WORKSHOP Michal Gillon Introduction Eran Segal - Personalized Medicine Approaches for Treatment of Based on Gut Microbiota Stavroula Mougiakakou - The future role of machine learning and computer vision in carbohydrate estimation for diabetic patients Guido Freckmann - Study Design and Execution Lutz Heinemann - Results Norbert Hermanns - Patient Related Outcomes Hans DeVries - Independent Commentary Deborah Mullen Using Glucose Profiles (AGP) for Shared Decision Making Mark Clements Machine Learning to Improve T1D Care Revital Nimri - Automated Decision Support System for Medical Team Who Treats Patients with Type 1 Ragnar Hanas - Technology in the <6-year-old Population Laurel Messer - Practical Issues in School with Technology
6 Andrea Scaramuzza - Efficacy of an APP to Count Carbs and Beyond to Limit the Postmeal Glucose Rise in Children with Type 1 Boris Kovatchev - Decision Support Systems Eda Cengiz - Technology in Adolescents and Young Adults Eduardo Calliari - Technology in Developing Countries
7 Saturday, 17 February :30-10:00 10:00-10:30 10:30-12:00 SESSION (17) DEBATE: CAN DIGITAL HEALTH REPLACE THE HCP? Revital Nimri Pro Lori Laffel con Discussion SESSION (20) PUMPS, SENSORS & FGM WHERE DO WE GO? SESSION (18) DIABETESINDIA SYMPOSIUM S. R. Aravind - Evolution of Technologies in India Manoj Chawla - Use of Insulin Pump Therapy in India - The Changing Perspective Jothydev Kesavadev - SMBG and Virtual Consultation DTMS (R): 20 Years' Experience Banshi Saboo - CGM & AGP - How to Reap Its Benefit From Busy Clinics in India? SESSION (21) PRACTICAL CLOSED LOOP THERAPY: EDUCATION AND IMPLEMENTATION SESSION (19) DIABETES TECHNOLOGY FOR TYPE 2 DIABETES Yves Reznik - Insulin Pump and CGM Eric Renard - Artificial Pancreas Marc Breton - Decision Tools SESSION (22) TURKISH DIABETES TECHNOLOGY GROUP: GLYCEMIC VARIATION IN DIABETES CONTROL SESSION 4 SESSION 5 SESSION 6 John Pickup - What Determines the Effectiveness of Insulin Pump Therapy: Towards Precision Technology? Jan Bolinder - Review of Flash Glucose Monitoring Benefits vs Capillary and vs CGM Nebojsa Lalic - Insulin Pump Treatment in Type 2 : Laurel Messer - Artificial Pancreas: Managing Expectations, Misconceptions and Preparing Patients for Success Sarah Biester- Train the Trainer: What do Clinicians Need to Understand About CL Technology? Damla Göksen - Glycemic Variability vs Glucose Control in Children Selçuk Dağdelen - Glycemic Variability vs Glucose Control in Adults Eda Cengiz - New Short and Long Acting Insulin Analogues and Glycemic Variability
8 Impact on Insulin Resistance and Related Metabolic Parameters Riccardo Bonfanti - CGM Standalone in Children Using Multiple Daily Injections Jennifer Sherr - Patients Perspective on Closed- loop Technology Barbara Murn Berkopec - Addressing Barriers to CGM and CL Therapies 12:00-13:00 13:00-13:05 13:05-13:45 PLENARY SESSION (23) SURGICAL AND PHARMACEUTICAL SOLUTIONS FOR OBESE PEOPLE WITH TYPE 2 DIABETES Francesco Rubino - Insulin-independent Mechanisms of Action of Bariatric/Metabolic Surgery Walter Pories The Downside to Metabolic (bariatric) Surgery Timo Müller Novel Pharmacological Approaches to Treat Obesity and T2 CLOSING REMARKS AND FAREWELL Tadej Battelino Farewell refreshments in the Exhibition Area
PRELIMINARY SCIENTIFIC PROGRAM As of 29 January Wednesday, 14 February 2018 HALL HALL B HALL L3 HALL M HALL N 14:30-16:00
PRELIMINARY SCIENTIFIC PROGRAM As of 29 January 2018 Plenary session Parallel Session Break Industry Session Oral Presentation Session Ask the speaker feature in App Voting feature in App Wednesday, 14
More informationSCIENTIFIC PROGRAM. PARALLEL INDUSTRY WORKSHOP Industry session not included in main event PARALLEL INDUSTRY WORKSHOP
1 SCIENTIFIC PROGRAM Wednesday, 15 February, 2017 Blue Amphitheater Maillot 252 PARALLEL INDUSTRY WORKSHOP PARALLEL INDUSTRY WORKSHOP PARALLEL INDUSTRY WORKSHOP 14:30-16:00 Industry session not included
More informationPreliminary Scientific Program As of January 1, Wednesday, 20 February 2019 HALL A7 A2 A3 M1 14:30-16:00
Preliminary Scientific Program As of January 1, 2019 Plenary Session Parallel Session Oral Presentation Session Industry Session Break Wednesday, 20 February 2019 A7 A2 A3 M1 14:30-16:00 WORKSHOP SYMPOSIUM
More informationPreliminary Scientific Program As of October 25, Wednesday, 20 February 2019 SYMPOSIUM 16:15-17:45
Preliminary Scientific Program As of October 25, 2018 Plenary Session Parallel Session Oral Presentation Session Industry Session Break Wednesday, 20 February 2019 14:30-16:00 INDUSTRY SYMPOSIUM INDUSTRY
More informationPreliminary Scientific Program As of December 16, Wednesday, 20 February 2019 PARALLEL INDUSTRY SYMPOSIUM 16:15-17:45 18:00-19:00
Preliminary Scientific Program As of December 16, 2018 Plenary Session Parallel Session Oral Presentation Session Industry Session Break Wednesday, 20 February 2019 14:30-16:00 WORKSHOP WORKSHOP SYMPOSIUM
More informationScientific Program As of January 3, Wednesday, 20 February 2019 HALL A7 A2 A3 M1 14:30-16:00
Scientific Program As of January 3, 2019 Plenary Session Parallel Session Oral Presentation Session Industry Session Break Wednesday, 20 February 2019 A7 A2 A3 M1 14:30-16:00 WORKSHOP INDUSTRY SESSION
More informationPRACTICAL WAYS TO ACHIEVE TARGETS IN DIABETES CARE July 12-15, 2012 Keystone, Colorado
PRACTICAL WAYS TO ACHIEVE TARGETS IN DIABETES CARE Thursday, July 12, 2012 CONFERENCE SCHEDULE 10:00-12:30 PM Registration/View Exhibits/Snacks 12:30 12:40 PM Welcome and Introductory Remarks Satish K.
More informationThe Digital Clinic: Unlock the Power of Diabetes Data Eran Atlas - CEO Copyright DreaMed Diabetes, Ltd. 2017, All Rights Reserved
The Digital Clinic: Unlock the Power of Diabetes Data Eran Atlas - CEO Basic Copyright Notice & Disclaimer Basic Copyright Notice & Disclaimer 2017 This presentation is copyright protected. All rights
More informationMEDTRONIC SCIENTIFIC PROGRAM
SCIENTIFIC PROGRAM ATTD 2017 15 th - 18 th PARIS, FRANCE Our vision at Medtronic is to transform diabetes care by working closely with you, so people living with diabetes can enjoy greater freedom and
More informationJDRF Perspective on Closed Loop
JDRF Perspective on Closed Loop Aaron J. Kowalski, Ph.D. Assistant Vice President Treatment Therapies Juvenile Diabetes Research Foundation International 1 Presenter Disclosure Aaron Kowalski Disclosed
More informationMore Than 1 Year of Hybrid Closed Loop in Pediatrics. Gregory P. Forlenza, MD Assistant Professor Barbara Davis Center
More Than 1 Year of Hybrid Closed Loop in Pediatrics Gregory P. Forlenza, MD Assistant Professor Barbara Davis Center Disclosure Dr. Forlenza has served as a consultant for Abbott Diabetes Care and conducts
More informationFuture Direction of Artificial Pancreas. Roy W. Beck, MD, PhD. JAEB Center for Health Research Tampa, Florida
Future Direction of Artificial Pancreas Roy W. Beck, MD, PhD JAEB Center for Health Research Tampa, Florida Financial Disclosures Dr. Beck does not have any personal conflicts of interest His employer,
More informationWhat is a CGM? (Continuous Glucose Monitor) The Bionic Pancreas Is Coming
The Bionic Pancreas Is Coming Montana Diabetes Professional Conference October 23, 2014 H. Peter Chase, MD Professor of Pediatrics University of Colorado Barbara Davis Center Stanford: Bruce Buckingham,
More informationCanaccord Growth Conference August confidently live life with ease
Canaccord Growth Conference August 2018 confidently live life with ease Forward-Looking Statements This presentation contains forward-looking statements that are not purely historical regarding Senseonics
More informationThe artificial pancreas: the next step in connectivity and digital treatment of type 1 diabetes
The artificial pancreas: the next step in connectivity and digital treatment of type 1 diabetes Roman Hovorka PhD FMedSci University of Cambridge, UK Duality of interest declaration Advisory Panel: Research
More informationCGM and Closing The Loop
CGM and Closing The Loop Dualities Research: Helmsely Charitable Trust, ADA, JDRF, NIDDK Consulting: Abbott Diabetes Care, Roche, Intarcia, Valeritas, Adocia, Big Foot Like With Pumps, We ve Come A Long
More informationATTD 2018 Invited Speaker Abstracts A-1
ATTD 2018 Invited Speaker Abstracts A-1 ATTD 2018 Oral Abstracts A-11 ATTD 2018 E-Poster Discussion Abstracts A-36 ATTD 2018 E-Poster Viewing Abstracts A-48 ATTD 2018 Read By Title A-149 ATTD 2018 Abstract
More informationReduction in Hypoglycemia and No Increase in A1C with Threshold-Based Sensor-Augmented Pump (SAP) Insulin Suspension: ASPIRE In-Home
Reduction in Hypoglycemia and No Increase in A1C with Threshold-Based Sensor-Augmented Pump (SAP) Insulin Suspension: ASPIRE In-Home Richard M. Bergenstal 1, David C. Klonoff 2, Bruce W. Bode 3, Satish
More informationQUESTION 4. WHAT CLINICAL DATA ARE CURRENTLY AVAILABLE TO SUPPORT EXPANDED CGM COVERAGE BY PAYERS AS PERTAINS TO QUESTIONS 1 AND 3?
500 1 QUESTION 4. WHAT CLINICAL DATA ARE CURRENTLY AVAILABLE TO SUPPORT EXPANDED CGM COVERAGE BY PAYERS AS PERTAINS TO QUESTIONS 1 AND 3? WHAT ADDITIONAL DATA ARE NEEDED? AACE/ACE CGM Consensus Conference:
More informationArtificial Pancreas Device System (APDS)
Medical Policy Manual Durable Medical Equipment, Policy No. 77 Artificial Pancreas Device System (APDS) Next Review: October 2019 Last Review: October 2018 Effective: November 1, 2018 IMPORTANT REMINDER
More informationCONFERENCE SCHEDULE. Wednesday, July 11, Thursday, July 12, PLENARY ONE: Glucose Control, Lipids, and CVD Chair: Marian Rewers, MD, PhD
4:00 7:00 PM Early Registration CONFERENCE SCHEDULE Wednesday, July 11, 2018 Thursday, July 12, 2018 10:00 11:30 PM Registration/View Exhibits/Snacks 11:30 12:00 PM Welcome and Introductory Remarks Satish
More informationPREVENTION OF NOCTURNAL HYPOGLYCEMIA USING PREDICTIVE LOW GLUCOSE SUSPEND (PLGS)
PREVENTION OF NOCTURNAL HYPOGLYCEMIA USING PREDICTIVE LOW GLUCOSE SUSPEND (PLGS) Pathways for Future Treatment and Management of Diabetes H. Peter Chase, MD Carousel of Hope Symposium Beverly Hilton, Beverly
More informationWhat is the role of insulin pumps in the modern day care of patients with Type 1 diabetes?
What is the role of insulin pumps in the modern day care of patients with Type 1 diabetes? Dr. Fiona Wotherspoon Consultant in Diabetes and Endocrinology Dorset County Hospital Fiona.Wotherspoon@dchft.nhs.uk
More information[Frida Svendsen and Jennifer Southern] University of Oxford
In adolescents with poorly controlled type 1 diabetes mellitus, could a bionic, bihormonal pancreas provide better blood glucose control than continuous subcutaneous insulin infusion therapy? [Frida Svendsen
More informationGlucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes
DIABETES TECHNOLOGY & THERAPEUTICS Volume 19, Number 3, 2017 Mary Ann Liebert, Inc. DOI: 10.1089/dia.2016.0421 ORIGINAL ARTICLE Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery
More informationCAROLINAS CHAPTER/AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS Annual Meeting HILTON HEAD ISLAND FRIDAY PRESENTATION
CAROLINAS CHAPTER/AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS 2016 Annual Meeting HILTON HEAD ISLAND FRIDAY PRESENTATION September 9-11, 2016 ~ Sonesta Resort ~ Hilton Head Island, SC This continuing
More informationWednesday, July 15, 2015
CONFERENCE SCHEDULE 4:00 7:00 PM Early Registration Wednesday, July 15, 2015 Thursday, July 16, 2015 10:00 12:00 PM Registration/View Exhibits/Snacks 12:00 12:30 PM Welcome and Introductory Remarks: Satish
More informationArtificial Pancreas Device Systems. Populations Interventions Comparators Outcomes. pump. pump
Protocol Artificial Pancreas Device Systems (10130) Medical Benefit Effective Date: 04/01/18 Next Review Date: 01/19 Preauthorization Yes Review Dates: 03/15, 03/16, 03/17, 01/18 Preauthorization is required.
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Phillip M, Battelino T, Atlas E, et al. Nocturnal glucose control
More informationTechnology in Diabetes Management Irl B. Hirsch, MD University of Washington
Technology in Diabetes Management 2016 Irl B. Hirsch, MD University of Washington Dualities Research: Helmsley Charitable Trust, JDRF, ADA, NIDDK, CDC Consulting: Abbott, Roche, Intarcia Raise Your Hand
More informationArtificial Pancreas Technologies: New Tools to Improve Diabetes Care Today and Tomorrow
Artificial Pancreas Technologies: New Tools to Improve Diabetes Care Today and Tomorrow Mark D. DeBoer, MD, MSc., MCR University of Virginia Center for Diabetes Technologies October 2017 Learning Objectives
More informationAdvances Towards the Bionic Pancreas.
Advances Towards the Bionic Pancreas. Ron Brazg MD, FACE Rainier Clinical Research Center Renton, WA DISCLOSURES Rainier Clinical Research Center is an independent research facility not directly affiliated
More informationArtificial Pancreas Device Systems. Populations Interventions Comparators Outcomes Individuals: With type 1 diabetes
Protocol Artificial Pancreas Device Systems Medical Benefit Effective Date: 07/01/18 Next Review Date: 01/20 Preauthorization Yes Review Dates: 03/15, 03/16, 03/17, 01/18, 05/18, 01/19 Preauthorization
More informationNorbert Hermanns, PhD 1,2, Beatrix Schumann, MD 2, Bernhard Kulzer, PhD 1,2, and Thomas Haak, MD 1,2. Original Article
524105DSTXXX10.1177/1932296814524105Journal of Diabetes Science and TechnologyHermanns et al research-article2014 Original Article The Impact of Continuous Glucose Monitoring on Low Interstitial Glucose
More informationInsulin Pump Therapy in children. Prof. Abdulmoein Al-Agha, FRCPCH(UK)
Insulin Pump Therapy in children Prof. Abdulmoein Al-Agha, FRCPCH(UK) aagha@kau.edu.sa Highlights Evolution of insulin pump Pumps mimics Pancreas Goals of diabetes care What lowers HbA1c Criteria for selection
More informationPsychological Reactions Associated With Continuous Glucose Monitoring in Youth
638109DSTXXX10.1177/1932296816638109Journal of Diabetes Science and TechnologyPatton and Clements research-article2016 Special Section Psychological Reactions Associated With Continuous Glucose Monitoring
More informationPresented by Dr. Bruce Perkins, MD MPH Dr. Michael Riddell, PhD
Type 1 Diabetes and Exercise: Optimizing the Medtronic MiniMed Veo Insulin Pump and Continuous Glucose Monitoring (CGM) for Better Glucose Control 1,2 for Healthcare Professionals Presented by Dr. Bruce
More informationControl of Glycemic Variability for Reducing Hypoglycemia Jae Hyeon Kim
Control of Glycemic Variability for Reducing Hypoglycemia Jae Hyeon Kim Division of Endocrinology and Metabolism, Samsung Medical Center, Sungkyunkwan University School of Medicine Conflict of interest
More informationEmerging Automated Insulin Delivery Systems
Emerging Automated Insulin Delivery Systems Richard M. Bergenstal, MD International Diabetes Center Park Nicollet & HealthPartners Minneapolis, MN Presenter Name 1 Dualities: Richard M. Bergenstal, MD
More informationDiabetes Management: Current High Tech Innovations
Diabetes Management: Current High Tech Innovations How Far We ve Come in the Last 40 Years William V. Tamborlane, MD Department of Pediatrics Yale School of Medicine Disclosures I am a consultant for:
More informationCowen Investor Conference March confidently live life with ease
Cowen Investor Conference March 2018 confidently live life with ease Forward-Looking Statements This presentation contains certain forward-looking statements that involve risks and uncertainties that could
More information1. Continuous Glucose Monitoring
1. Continuous Glucose Monitoring 1. Physiology of interstitial fluid glucose 2. Comparison of CGM and self-monitored blood glucose (SMBG) data 3. Insulin dosing indication in BGM vs. CGM & the FDA 4. Protection
More informationDIABETES TECHNOLOGY: WHERE ARE WE NOW AND WHERE ARE WE GOING? Presented by: Tom Brobson
DIABETES TECHNOLOGY: WHERE ARE WE NOW AND WHERE ARE WE GOING? Presented by: Tom Brobson March 3 rd, 2018 Who is this guy? Accelerating Progress 1 Oh that guy! Accelerating Progress 2 STATE OF T1D CARE
More informationJDRF RESEARCH UPDATE. Daniel Finan, Ph.D. Research Director
JDRF RESEARCH UPDATE Daniel Finan, Ph.D. Research Director March 10, 2018 PRESENTER Daniel Finan Biomedical engineer B.S. Chemical Engineering University of Colorado, 2003 Ph.D. Chemical Engineering UC
More informationT he ultimate goal of diabetes technology
D I A B E T E S Current Application of Continuous Glucose Monitoring in the Treatment of Diabetes Pros and cons JEROEN HERMANIDES, MD 1 MOSHE PHILLIP, MD, PHD 2 J. HANS DEVRIES, MD, PHD 1 T he ultimate
More informationHypoglycemia a barrier to normoglycemia Are long acting analogues and pumps the answer to the barrier??
Hypoglycemia a barrier to normoglycemia Are long acting analogues and pumps the answer to the barrier?? Moshe Phillip Institute of Endocrinology and Diabetes National Center of Childhood Diabetes Schneider
More informationOAMT ONCOLOGY ACCOUNT MANAGEMENT TRAINING. September 20 22, 2016 ARIA Resort & Casino, Las Vegas, NV. For the Life Sciences Industry
OAMT ONCOLOGY ACCOUNT MANAGEMENT TRAINING For the Life Sciences Industry September 20 22, 2016 ARIA Resort & Casino, Las Vegas, NV Register at DecisionResourcesGroup.com/Events DEAR COLLEAGUE, Cancer affects
More informationPaolo Di Bartolo U.O di Diabetologia Dip. Malattie Digestive & Metaboliche AULS Prov. di Ravenna. Ipoglicemie e Monitoraggio Glicemico
Paolo Di Bartolo U.O di Diabetologia Dip. Malattie Digestive & Metaboliche AULS Prov. di Ravenna Ipoglicemie e Monitoraggio Glicemico Management of Hypoglycaemia.if hypoglycemia is a problem, the principles
More informationArtificial Pancreas Goes Outpatient: A New Diabetes Ecosystem
Journal of Diabetes Science and Technology Volume 7, Issue 6, November 2013 Diabetes Technology Society EDITORIAL Artificial Pancreas Goes Outpatient: A New Diabetes Ecosystem Eric, M.D., Ph.D., 1,2,3
More informationThe Harvard community has made this article openly available. Please share how this access benefits you. Your story matters
Safety and Feasibility of the OmniPod Hybrid Closed-Loop System in Adult, Adolescent, and Pediatric Patients with Type 1 Diabetes Using a Personalized Model Predictive Control Algorithm The Harvard community
More informationImmunology/ Transplantation. Epidemiology/ Genetics. Mini-Symposium The Future Face of Diabetes Care Beta- Cell Replacement vs. Technology Room: 24
FRIDAY, JUNE 9 Registration Hours: 9:00 a.m.-6:30 p.m. Shop Store Hours: 9:00 a.m.-6:30 p.m. Clinical / 11:30 a.m.- 12:30 p.m. Mini- Clinical Innovation in Vision Mini- Exercise for Type 1 The Stigma of
More informationReduced Hypoglycemia and Increased Time in Target Using Closed-Loop Insulin Delivery During Nights With or Without Antecedent Afternoon Exercise
Clinical Care/Education/Nutrition/Psychosocial Research O R I G I N A L A R T I C L E Reduced Hypoglycemia and Increased Time in Target Using Closed-Loop Insulin Delivery During Nights With or Without
More informationNEWS BRIEFING Advances in Technology. moderated by: Irl Hirsch, MD University of Washington Medical Center
NEWS BRIEFING Advances in Technology moderated by: Irl Hirsch, MD University of Washington Medical Center 1 EMBARGO POLICY All recordings are for personal use only and not for rebroadcast online or in
More informationFebruary 27-March 2, 2013; Paris, France Full Report Draft
6 th International Conference on Advanced Technologies & Treatments for Diabetes Executive Highlights February 27-March 2, 2013; Paris, France Full Report Draft We were honored to be in the company of
More informationDiabetes Technology Continuous Subcutaneous Insulin Infusion Therapy And Continuous Glucose Monitoring In Adults: An Endocrine Society Clinical
Diabetes Technology Continuous Subcutaneous Insulin Infusion Therapy And Continuous Glucose Monitoring In Adults: An Endocrine Society Clinical Practice Guideline Task Force Members Anne Peters, MD (Chair)
More informationInsulin Pumps and Glucose Sensors in Diabetes Management
Diabetes Update+ 2014 Congress Whistler, British Columbia Friday March 21, 2014ǀ 8:15 8:45 am Insulin Pumps and Glucose Sensors in Diabetes Management Bruce A Perkins MD MPH Division of Endocrinology Associate
More informationClinical Value and Evidence of Continuous Glucose Monitoring
Clinical Value and Evidence of Continuous Glucose Monitoring 9402313-012 Objective To review the clinical value and the recent clinical evidence for Professional and Personal CGM Key Points CGM reveals
More informationThe In-Clinic Close Loop Experience in the US
The In-Clinic Close Loop Experience in the US Keystone Symposium, Practical Ways to Achieve Targets in Diabetes Care July 14, 2012 Francine Ratner Kaufman, MD Chief Medical Officer, VP Global Medical,
More informationFaculty Disclosure. No, nothing to disclose Yes, please specify: Novo-Nordisk. Roche. Abbott. Funded Research. Ownership/ Equity Position
Diabeloop Closed-Loop does better than sensor-augmented-pump on blood glucose during 3 days with intensive physical eercises: a randomized crossover trial. Sylvia Franc 1, MD, Sophie Borot, MD, PhD, Pierre-Yves
More informationPatrick J. Sullivan, President & CEO March 7, 2016 Raymond James 37 th Annual Institutional Conference
Patrick J. Sullivan, President & CEO March 7, 2016 Raymond James 37 th Annual Institutional Conference Forward Looking Statement This presentation may contain forward-looking statements concerning Insulet's
More informationReview Article. Continuous Glucose Monitoring - A Step Towards Better Diabetes Management. Ajay V Kaduskar
Review Article Vidarbha Journal of Internal Medicine Volume 24 January 2018 Continuous Glucose Monitoring - A Step Towards Better Diabetes Management 1 Ajay V Kaduskar ABSTRACT Self-monitoring of blood
More informationDiabetes Technology Update. Sarah Konigsberg, MD Diabetes & Endocrine Assoc. April 7, 2018
Diabetes Technology Update Sarah Konigsberg, MD Diabetes & Endocrine Assoc. April 7, 2018 Disclosures None No future technologies are FDA approved Continuous Glucose Monitors Continuous Glucose Monitors
More informationThe Artificial Pancreas
SAGLB.DIA.15.2.87(2). Approved October 215 The Artificial Pancreas For scientific and medical purposes only The pancreas responds to changes in blood glucose by releasing insulin (β cells) to lower blood
More informationJames J. Chamberlain, MD 1, Dana Dopita, RN, MSN, CDE 1, Emily Gilgen, RD, CD, CDE 1, and Annie Neuman, MPA, PA-C 1.
604633DSTXXX10.1177/1932296815604633Journal of Diabetes Science and TechnologyChamberlain et al research-article2015 Original Article Impact of Frequent and Persistent Use of Continuous Glucose Monitoring
More informationInformation Overload! CGM, Navigating for Success. Presented by: Kathi Milton RD, CDE and Amy Foreman RN, CDE
Information Overload! CGM, Navigating for Success Presented by: Kathi Milton RD, CDE and Amy Foreman RN, CDE CGM-What is it? Continuous Glucose Monitor: a device that provides measurement of glucose data,
More informationInpatient Studies of a Kalman-Filter-Based Predictive Pump Shutoff Algorithm
Journal of Diabetes Science and Technology Volume 6, Issue 5, September 2012 Diabetes Technology Society ORIGINAL ARTICLE Inpatient Studies of a Kalman-Filter-Based Predictive Pump Shutoff Algorithm Fraser,
More informationInternational Neuromodulation Society 14th World Congress May 25-30, 2019, Preliminary Scientific Program*
Pre-Conference Days May 25-26 International Neuromodulation Society 14th World Congress May 25-30, 2019, Preliminary Scientific Program* *Subject to change May 25 - Pre-Conference: Noninvasive Brain Stimulation
More information1. Introduction Ljubljana, Slovenia 4 Department of Medical Psychology, Hannover Medical School, Hannover, Germany
Hindawi Publishing Corporation Journal of Diabetes Research Volume 2015, Article ID 590308, 8 pages http://dx.doi.org/10.1155/2015/590308 Clinical Study Reduced Worries of Hypoglycaemia, High Satisfaction,
More informationUvA-DARE (Digital Academic Repository) The artificial pancreas Kropff, J. Link to publication
UvA-DARE (Digital Academic Repository) The artificial pancreas Kropff, J. Link to publication Citation for published version (APA): Kropff, J. (2017). The artificial pancreas: From logic to life General
More informationPump and Sensor Data Interpretation. Irl B. Hirsch, MD University of Washington School of Medicine
Pump and Sensor Data Interpretation Irl B. Hirsch, MD University of Washington School of Medicine Dualities Research: Medtronic Diabetes Consulting: Abbott Diabetes Care, BD, Bigfoot, Roche Raise Your
More informationDiabetes Management Continuous Glucose Monitoring
Progress with Closed-loop Systems in Type 1 Diabetes Lalantha Leelarathna 1 and Roman Hovorka 2 1. Clinical Research Associate; 2. Principal Research Associate, Institute of Metabolic Science, University
More informationDexcom Current and Future Technology Innovations. Jorge Valdes Chief Technical Officer
Dexcom Current and Future Technology Innovations 2015 Jorge Valdes Chief Technical Officer G5 App Sensor (Same as G4) Indicated for adults and children down to Age 2 years Tiny insertion needle (26Ga)
More informationDo women have to come off DAFNE when pregnant?
Do women have to come off DAFNE when pregnant? Dr Helen R Murphy hm386@medschl.cam.ac.uk DAFNE Manchester June 26 2015 Topics for discussion Current practice in T1D pregnancy Reflect on current DAFNE guidelines
More informationDiabetes and Technology. Saturday, September 9, 2017 Aimee G sell, APRN, ANP-C, CDE
Diabetes and Technology Saturday, September 9, 2017 Aimee G sell, APRN, ANP-C, CDE Disclosure Speaker s Bureau: Janssan Pharmaceuticals Current Technology V-Go by Valeritas Continuous Sensors (personal
More informationFRIDAY, JUNE 21. Epidemiology/ Genetics. Symposium The Big Picture Genetic Architecture of Diabetes Room S 103 B
Registration Hours: 9:00 a.m. 6:30 p.m. Shop Store Hours: 9:00 a.m. 6:30 p.m. FRIDAY, JUNE 21 Noon 12:40 p.m. Meet the Expert Sessions 12:50 p.m. 1:30 p.m. Meet the Expert Sessions 2:00 p.m. 4:00 p.m.
More informationFaculty Disclosure. No, nothing to disclose Yes, please specify: Medtronic Johnson & Johnson. Ownership/ Equity Position.
Diabeloop Closed-Loop does better than Sensor-augmented Pump on blood glucose control during 3 days with gastronomic dinners: a randomized crossover trial in Patients with Type 1 Diabetes. Hélène Hanaire
More informationThe Realities of Technology in Type 1 Diabetes
The Realities of Technology in Type 1 Diabetes May 6, 2017 Rosanna Fiallo-scharer, MD Margaret Frederick, RN Disclosures I have no conflicts of interest to disclose I will discuss some unapproved treatments
More informationContinuous Glucose Monitoring (CGM)
Continuous Glucose Monitoring (CGM) Background Info A1c Average glucose levels over previous 2-3 months Currently remains gold standard for determining control Indicator of risk for development of complications
More informationBringing closed-loop home: recent advances in closed-loop insulin delivery
REVIEW C URRENT OPINION Bringing closed-loop home: recent advances in closed-loop insulin delivery Hood Thabit and Roman Hovorka Purpose of review To highlight the recent advances in closed-loop research,
More informationResearch Proposal. 1. Background and Rationale
1. Background and Rationale Insulin is secreted by the pancreatic beta cells and reduces blood glucose concentration (1). Glucagon is secreted by the pancreatic alpha cells and increases glucose concentration.
More informationISPAD Sponsor and Exhibitor Guide 40 TH ANNIVERSARY. Diversity in Diabetes
40 TH ANNUAL CONFERENCE International Society for Pediatric and Adolescent Diabetes ISPAD 2014 40 TH ANNIVERSARY September 3 rd 6 th, 2014 Toronto, Canada Diversity in Diabetes Sponsor and Exhibitor Guide
More informationNewsletter May, Recent advances in. Life Sciences
Newsletter May, 2018 Recent advances in Life Sciences VOLUME 1/ISSUE 2 WWW.MAXVAL.COM IN THIS ISSUE: 01 Base Editors in CRISPR This article presents a base editing approach to expand the scope and efficiency
More informationHow I use the latest technology to investigate and treat a person with Type 1 Diabetes. Dr Pratik Choudhary
How I use the latest technology to investigate and treat a person with Type 1 Diabetes Dr Pratik Choudhary Disclosures Advisory board and speaker fees from Medtronic, Roche, Abbott and Johnson and Johnson,
More informationATTD Session: Needs and solutions in Type 1 diabetes from youth to seniors: towards software prescriptions
ATTD Session: Needs and solutions in Type 1 diabetes from youth to seniors: towards software prescriptions Moshe Phillip MD The Jesse Z and Sara Lea Shafer Institute for Endocrinology and Diabetes National
More informationHome Use of an Artificial Beta Cell in Type 1 Diabetes
The new england journal of medicine Original Article Home Use of an Artificial Beta Cell in Type 1 Diabetes H. Thabit, M. Tauschmann, J.M. Allen, L. Leelarathna, S. Hartnell, M.E. Wilinska, C.L. Acerini,
More informationContinuous or Intermittent Glucose Monitoring in Interstitial Fluid
Continuous or Intermittent Glucose Monitoring in Interstitial Fluid Policy Number: 1.01.20 Last Review: 9/2014 Origination: 11/2001 Next Review: 9/2015 Policy Blue Cross and Blue Shield of Kansas City
More informationEVALUATION OF GLUCOSE MONITORING TECHNOLOGIES FOR COST EFFECTIVE AND QUALITY CONTROL/MANAGEMENT OF DIABETES
EVALUATION OF GLUCOSE MONITORING TECHNOLOGIES FOR COST EFFECTIVE AND QUALITY CONTROL/MANAGEMENT OF DIABETES David P. Paul, III Monmouth University Stacy Ashworth, Leslie Salyers, Sarah Saldanha and Alberto
More informationDeveloping an Artificial Pancreas The History & Future of Dose Safety
Developing an Artificial Pancreas The History & Future of Dose Safety Richard Mauseth, MD!! IMPROVING!!! LIVES.!CURING!!TYPE!1 DIABETES. Controller Methods 1. Proportional-Integral-Derivative (PID) 2.
More informationFlorida Network Symposium
Katrina J. Ruedy, MSPH John W. Lum, MS Jaeb Center for Health Research NE Florida Network Symposium In Conjunction with The 28th Annual Clinical Conference on Diabetes Jaeb Center for Health Research (JCHR)
More informationType 2 diabetes Priority Setting Partnership (PSP) FREQUENTLY ASKED QUESTIONS
Type 2 diabetes Priority Setting Partnership (PSP) FREQUENTLY ASKED QUESTIONS What is a Priority Setting Partnership (PSP)? Priority Setting Partnerships focus on a particular condition or healthcare issue.
More informationInterpretation of Continuous Glucose Monitoring (CGM) Data
Interpretation of Continuous Glucose Monitoring (CGM) Data Sherri Horvat, BSN, RN, CDE Blood Glucose Manager, Animas Corporation A Johnson & Johnson Diabetes Care Company Overview of CGM Continuous glucose
More informationReal-time Continuous Glucose Recording: An analysis of end user self-reported experiences
Real-time Continuous Glucose Recording: An analysis of end user self-reported experiences Author: Tim Street Abstract Objective: This study analyzed user's views on their use of real-time continuous glucose
More informationDIABETES - FACT SHEET
DIABETES - FACT SHEET What is diabetes? Diabetes mellitus, often shortened to diabetes, is a chronic condition that affects the body's ability to control blood sugar level and use energy from food. In
More information6TH INTERNATIONAL CONFERENCE ON NUTRITION & GROWTH THURSDAY, 7 MARCH 2019 Auditorium 1 Auditorium 2 Auditorium 3
6TH INTERNATIONAL CONFERENCE ON NUTRITION & GROWTH THURSDAY, 7 MARCH 2019 Before the first 1000 days: before conception and after birth 13:00-14:30 Chairs: Andrew Prentice and Kim F. Michaelsen Influence
More informationInsulin Delivery and Glucose Monitoring Methods for Diabetes Mellitus: Comparative Effectiveness
Insulin Delivery and Glucose Monitoring Methods for Diabetes Mellitus: Comparative Effectiveness Prepared for: Agency for Healthcare Research and Quality (AHRQ) www.ahrq.gov Outline of Material Introduction
More information